FinalSpark

FinalSpark is a Swiss private company founded in 2014 by scientists and entrepreneurs Fred Jordan and Martin Kutter in Vevey, Switzerland. The company is developing biological processors, or bioprocessors, that use cultured neural tissue to perform computational tasks. Its research focuses on creating computing systems that exploit biological networks derived from human cells, specifically induced pluripotent stem cells (iPSCs) obtained from skin cells. According to the company, these cellular structures are grown as brain organoids and then arranged on electrode arrays for experimental purposes. FinalSpark operates a laboratory in Vevey that can be accessed physically or remotely through an online interface. The team includes specialists from signal processing, physics, neuroscience, and cell biology. The company positions biocomputing as the next evolutionary leap for AI, arguing that traditional silicon-based computing is limited by high energy consumption. FinalSpark cites the human brain's efficiency—86 billion neurons using only about 20 watts—as inspiration, noting that replicating such efficiency with silicon would require roughly 10 megawatts according to Stanford University's Kwabena Boahen. FinalSpark's approach uses wetware-based biocomputing, which it describes as self-organizing and capable of continuous learning, inherently "one for many" rather than one system for a single task. The company claims its bioprocessors are energy-efficient and scalable. FinalSpark's experimental platform involves developing human neural tissue from iPSCs, forming neurospheres, and connecting them to electrode circuits to perform computational operations. The remote laboratory, called "Neuroplatform," allows scientists to interact with these networks via Python scripts. The company is among private enterprises active in biological computing (wetware) and what some researchers call "organoid intelligence," alongside players such as Koniku (United States) and Cortical Labs (Australia). Initially founded with a focus on conventional computing hardware, FinalSpark reoriented its research in 2019 toward using neural cell networks as hardware for computing devices. As of 2024, FinalSpark remains a private company funded by its founders, who also draw on resources from an earlier company, AlpVision, created in 2001. Fred Jordan and Martin Kutter are the masterminds behind AlpVision.com, a global anti-fraud system used by some of the largest industries worldwide, and they have created life.alpvision.com, a platform harnessing AI and other disruptive solutions in biotech and pharma. They hold over 80 patents for their forward-thinking expertise.

FinalSpark was founded in 2014 by Fred Jordan and Martin Kutter in Vevey, Switzerland. Initially, the company focused on conventional computing hardware. In 2019, FinalSpark reoriented its research toward using neural cell networks as hardware for computing devices. As of 2024, FinalSpark remains a private company funded by its founders, who also draw on resources from an earlier company, AlpVision, created in 2001. Fred Jordan and Martin Kutter are the masterminds behind AlpVision.com, a global anti-fraud system used by some of the largest industries worldwide, and they have created life.alpvision.com, a platform harnessing AI and other disruptive solutions in the biotech and pharma sectors. They hold over 80 patents for their forward-thinking expertise. The company has been developing biological processors from cultured neural tissue, and its research focuses on creating computing systems that exploit biological networks derived from human cells, specifically induced pluripotent stem cells (iPSCs) obtained from skin cells. According to the company, these cellular structures are grown as brain organoids and then arranged on electrode arrays for experimental purposes. FinalSpark operates a laboratory in Vevey that can be accessed physically or remotely through an online interface. The team includes specialists from signal processing, physics, neuroscience, and cell biology. The company is among private enterprises active in biological computing (wetware) and what some researchers call "organoid intelligence," alongside players such as Koniku (United States) and Cortical Labs (Australia).

• 2024

  As of 2024, FinalSpark remains a private company funded by its founders.

• 2023

  Published article 'Biocomputing – The next evolutionary leap' on July 11, 2023.

• 2019

  FinalSpark reoriented its research toward using neural cell networks as hardware for computing devices.

• 2014

  FinalSpark founded by Fred Jordan and Martin Kutter in Vevey, Switzerland.

Pioneering biocomputing as the next evolutionary leap for AI, offering energy-efficient and scalable biological processors.

• Neuroplatform

  Remote laboratory allowing scientists to interact with biological neural networks via Python scripts.

• Bioprocessors

  Biological processors using cultured human neural tissue for computational tasks.

1. 1Home - FinalSparkfinalspark.com
2. 2Biocomputing - The next evolutionary leapfinalspark.com
3. 3FinalSpark - Wikidatawikidata.org
4. 4FinalSpark - Wikipedia (French)fr.wikipedia.org